AHRQ Vitamin D/Calcium Report Draws Industry Fire
This article was originally published in The Tan Sheet
The U.S. Preventive Service Task Force releases a meta-analysis looking at whether available research supports an association between the use of vitamin D and calcium and fracture prevention. Trials of vitamin D use alone or with calcium showed no statistically significant reduction in fractures among subjects in the control groups, the panel found.
You may also be interested in...
New bone-targeted agents for osteoporosis must clear significant obstacles to succeed in a highly generic market, but safety concerns with established agents like bisphosphonates and calcitonin offer a foothold. Phase III anabolic candidates from Amgen and Radius Health aim to build new bone, the holy grail of osteoporosis treatment, but R&D in new anti-resorptive mechanisms to halt bone breakdown also continues.
Presenters at the IFT Wellness conference recommend that nutrition science move beyond randomized controlled trials – which typically are ill-suited to assess nutrient benefits – so development of new food and supplement products is not impeded.